secwatch / observer
8-K filed June 21, 2024, 7:59 PM ET ticker TRAW CIK 0001130598
leadership confidence high sentiment negative materiality 0.65

Traws Pharma President & CSO Oncology resigns; Board disputes severance claim

Traws Pharma, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Steven M. Fruchtman

President and Chief Scientific Officer, Oncology
TRAW · Traws Pharma, Inc.
Effective
2024-06-17
Filed
June 21, 2024, 7:59 PM ET
On June 17, 2024, Steven M. Fruchtman informed the board of directors (the “Board”) of Traws Pharma, Inc. (the “Company”) of his intent to resign from his positions of President and Chief Scientific Officer, Oncology.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Steven M. Fruchtman resigned as President and Chief Scientific Officer, Oncology at Traws Pharma, Inc..

Action
resigned
Role
President and Chief Scientific Officer, Oncology
Exact text from the filing
On June 17, 2024, Steven M. Fruchtman informed the board of directors (the “Board”) of Traws Pharma, Inc. (the “Company”) of his intent to resign from his positions of President and Chief Scientific Officer, Oncology.
View on SEC.gov

Traws Pharma, Inc. filing history →

Source: SEC EDGAR
accession 0001104659-24-074003
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.